Four studies [5], [6], [8], [9] (83%) provided data on disease recurrence for subgroups of patients with ER-positive primary breast cancer (i.e. after excluding ER-negative and ER-unknown cases if applicable); while in one study [7] only data on a combined group of ER-positive and ER-unknown were available. Here, ESR1 is linked to breast cancer.